These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33115620)

  • 1. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
    Hyland CA; O'Brien H; Flower RL; Gardener GJ
    Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal
    Clausen FB
    Immunohematology; 2024 Apr; 40(1):15-27. PubMed ID: 38739027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of non-invasive prenatal testing (NIPT) for fetal blood group typing in Australia.
    Ginige S; Daly J; Hyland C; Powley T; O'Brien H; Moreno AM; Gardener G; Flower R
    Aust N Z J Obstet Gynaecol; 2022 Feb; 62(1):33-36. PubMed ID: 34661280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
    Kent J; Farrell AM; Soothill P
    BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe foetal anaemia caused by undetected alloimmunisation in a RhD-positive pregnant woman].
    Krabek R; Bergholt T; Johansen M; Nørgaard LN; Heiring C; Dziegiel MH; Ekelund CK
    Ugeskr Laeger; 2021 Aug; 183(32):. PubMed ID: 34378528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.
    Alshehri AA; Jackson DE
    Transfus Med Rev; 2021 Apr; 35(2):85-94. PubMed ID: 33781630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis.
    Yang H; Llewellyn A; Walker R; Harden M; Saramago P; Griffin S; Simmonds M
    BMC Med; 2019 Feb; 17(1):37. PubMed ID: 30760268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.
    Saramago P; Yang H; Llewellyn A; Walker R; Harden M; Palmer S; Griffin S; Simmonds M
    Health Technol Assess; 2018 Mar; 22(13):1-172. PubMed ID: 29580376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
    Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
    PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities.
    Floch A
    Transfus Clin Biol; 2021 Aug; 28(3):314-320. PubMed ID: 33895380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
    Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
    BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from the implementation of non-invasive fetal RHD screening.
    Clausen FB
    Expert Rev Mol Diagn; 2018 May; 18(5):423-431. PubMed ID: 29616835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemolytic disease of the fetus and newborn.
    de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
    Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal red blood cell alloimmunisation in south western Uganda.
    Natukunda B; Mugyenyi G; Brand A; Schonewille H
    Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New approaches to prenatal diagnosis of rhesus incompatibility].
    Minon JM; Gérard C; Dricot JF; Neve C; Senterre JM; Schaaps JP; Foidart JM
    Rev Med Liege; 2006 Nov; 61(11):756-62. PubMed ID: 17191743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.